when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Bispecific Antibody · news · pharmadog

← back to Bispecific Antibody

News · Bispecific Antibody

209 stories

Aug 17, 26Summit, Akeso’s China approval celebration cut short as survival benefit degradesbiospace

Aug 17, 26Regeneron ends eye disease trial for anti-CD3 antibody following safety reviewfiercebiotech

Aug 17, 26AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blowbiospace

Aug 17, 26AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blowbiospace

Aug 17, 26J&J hands lymphoma bispecific CAR T back to AbelZetabiospace

Aug 17, 26Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trialsfiercebiotech

Aug 17, 26Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vaguefiercebiotech

Aug 17, 26AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytrudafiercebiotech

Aug 14, 26Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myersbiopharma dive

Aug 13, 26Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competitionbiospace

Aug 13, 26PDS halts work on phase 3 cancer therapy to focus on colorectal contenderfiercebiotech

Aug 13, 26Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goalfiercebiotech

Aug 12, 26Boulevard starts up with $65M to pursue targeted autoimmune drugsbiopharma dive

Aug 11, 26Chasing Dupixent, a biotech aims to make better antibody drugs for eczemabiopharma dive

Aug 11, 26Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugsfiercebiotech

Aug 11, 26After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’fiercebiotech

Aug 10, 26‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorderfiercebiotech

Aug 10, 26Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drugfiercebiotech

Aug 6, 26Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027fiercebiotech

Aug 5, 26Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPOfiercebiotech

Aug 4, 26J&J pharma leader to retire; Krystal slumps on gene therapy missbiopharma dive

Aug 4, 26Pathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamabbiospace

Aug 4, 26Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pactfiercebiotech

Aug 3, 26BioNTech taps Sobi executive Oelkers as its next CEObiopharma dive

Aug 3, 26BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechbiospace

Aug 3, 26After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech

Jul 29, 26Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergersbiospace

Jul 29, 26Two biotechs sign reverse mergers to advance I&I drug, BTK inhibitorendpoints

Jul 29, 26Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combinationfiercebiotech

Jul 29, 26‘Reverse mergers are increasingly popular’: Caldera hops on Synlogic’s Nasdaq listingfiercebiotech

← prevpage 3 of 7next →